Double-vessel very late stent thrombosis following Resolute Onyx zotarolimus eluting stents implantation in an octogenarian
George Kassimis
Tushar Raina
摘要：Compared with bare-metal stents (BMS),drug-eluting stents (DES) have shown better clinical outcomes for patients undergoing percutaneous coronary intervention (PCI) by inhibition of neo-intimal hyperplasia,[1] However,earlygeneration DES produced late thrombotic events,more than l-year,by delaying arterial healing of stented vessels.[2-5] New-generation DES have been developed with thinner stent struts,more biocompatible polymer coatings for drug release,and a variety of antiproliferative agents with similar or superior anti-restenotic efficacy.[6] This development has led to a significant improvement in the efficacy and safety of new-generation DES,and consistently lower rates of very late stent thrombosis (VLST).[7,8] In fact,use of new-generation DES is the standard treatment in contemporary PCI practice.
机标关键词：
论文发表日期：2018-10-26
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：5( 639-643 )
英文信息